Nuwellis announces ULTRA-Peds registry study findings on Aquadex System in pediatric AKI

Nuwellis, Inc.

ULTRA-Peds registry is multi-center observational study of real-world Aquadex System use.
Study focused on children with acute kidney injury, fluid overload, or congenital kidney failure.
Findings announced September 30, 2025; no quantitative results or patient numbers disclosed.
Company did not provide financial impact or guidance change in this filing.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.